Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helene Højsgaard Chow

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2018
Dimethyl fumarate therapy suppresses B cell responses and follicular helper T cells in relapsing-remitting multiple sclerosisRikke Holm Hansen, Helene Højsgaard Chow, Finn Sellebjerg, et al.
Frontiers in Immunology|September 25, 2023
Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell controlMarina Rode von Essen, Helene Højsgaard Chow, Rikke Holm Hansen, et al.
Neuropsychological Rehabilitation|May 16, 2025
Cognitively stimulating activities in multiple sclerosis: A qualitative feasibility studyAndreas Kirknæs Færk, Jakob Lindegaard Lund, Finn Sellebjerg, et al.
Multiple Sclerosis and Related Disorders|May 29, 2026
Cognitively stimulating activities in multiple sclerosis: Results of a randomized controlled trialAndreas Kirknæs Færk, Finn Sellebjerg, Jakob Lindegaard Lund, et al.
Multiple Sclerosis and Related Disorders|November 2, 2019
Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosisRikke Holm Hansen, Helene Højsgaard Chow, Jeppe Romme Christensen, et al.
Journal of Neuroimmunology|December 9, 2019
MAIT cell subtypes in multiple sclerosisCecilie Ammitzbøll, Marina R von Essen, Helene Højsgaard Chow, et al.
Multiple Sclerosis and Related Disorders|October 22, 2021
Smoking, cardiovascular risk factors and LRP2 gene variation: Associations with disease severity, cognitive function and brain structure in primary progressive multiple sclerosisHelene Højsgaard Chow, Jacob Talbot, Lisbet Marstrand, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 27, 2023
Intrathecal CD8<sup>+</sup>CD20<sup>+</sup> T Cells in Primary Progressive Multiple SclerosisMarina Rode von Essen, Jacob Talbot, Rikke Holm Holm Hansen, et al.
Brain and Behavior|February 28, 2018
Progressive multiple sclerosis, cognitive function, and quality of lifeHelene Højsgaard Chow, Karen Schreiber, Melinda Magyari, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 3, 2022
Peripheral helper T cells in the pathogenesis of multiple sclerosisRikke Holm Hansen, Helene Højsgaard Chow, Jacob Talbot, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2018
Dimethyl fumarate therapy suppresses B cell responses and follicular helper T cells in relapsing-remitting multiple sclerosisRikke Holm Hansen, Helene Højsgaard Chow, Finn Sellebjerg, et al.
Frontiers in Immunology|September 25, 2023
Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell controlMarina Rode von Essen, Helene Højsgaard Chow, Rikke Holm Hansen, et al.
Neuropsychological Rehabilitation|May 16, 2025
Cognitively stimulating activities in multiple sclerosis: A qualitative feasibility studyAndreas Kirknæs Færk, Jakob Lindegaard Lund, Finn Sellebjerg, et al.
Multiple Sclerosis and Related Disorders|May 29, 2026
Cognitively stimulating activities in multiple sclerosis: Results of a randomized controlled trialAndreas Kirknæs Færk, Finn Sellebjerg, Jakob Lindegaard Lund, et al.
Multiple Sclerosis and Related Disorders|November 2, 2019
Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosisRikke Holm Hansen, Helene Højsgaard Chow, Jeppe Romme Christensen, et al.
Journal of Neuroimmunology|December 9, 2019
MAIT cell subtypes in multiple sclerosisCecilie Ammitzbøll, Marina R von Essen, Helene Højsgaard Chow, et al.
Multiple Sclerosis and Related Disorders|October 22, 2021
Smoking, cardiovascular risk factors and LRP2 gene variation: Associations with disease severity, cognitive function and brain structure in primary progressive multiple sclerosisHelene Højsgaard Chow, Jacob Talbot, Lisbet Marstrand, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 27, 2023
Intrathecal CD8<sup>+</sup>CD20<sup>+</sup> T Cells in Primary Progressive Multiple SclerosisMarina Rode von Essen, Jacob Talbot, Rikke Holm Holm Hansen, et al.
Brain and Behavior|February 28, 2018
Progressive multiple sclerosis, cognitive function, and quality of lifeHelene Højsgaard Chow, Karen Schreiber, Melinda Magyari, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 3, 2022
Peripheral helper T cells in the pathogenesis of multiple sclerosisRikke Holm Hansen, Helene Højsgaard Chow, Jacob Talbot, et al.
Pageof 2